Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIL-GVHD
NCT06247150Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- May 2024
- Primary completion
- May 2028
- Countries
- 1
01
Overview
Trial (2 arms), sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Description of immune landscape in chronic GVHD target tissue subsets. Started May 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06247150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06247150.